Principes généraux

  • atezolizumab (Tecentriq®)
  • avelumab (Bavencio®)
  • cemiplimab (Libtayo®)
  • durvalumab (Infimzi®)
  • ipilimumab (Yervoy®)
  • nivolumab (Opdivo®)
  • pembrolizumab (Keytruda®)